Latest News for Impedimed Stock (OTC:IPDQF)

Impedimed Ltd, together with its subsidiaries, operates in the medical devices space. The company is based in Australia and operates globally, and it generates most of its revenue in North America. It is engaged in developing, manufacturing, and distributing noninvasive medical devices. The company offers products that are typically used to assess and monitor lymphedema and heart failure, as well as to measure the tissue composition and fluid status of the patients. The company also offers a cloud-based digital platform (branded as SOZO) to manage patient data. The Company recognizes revenue from stand alone sale of Legacy Devices and Consumables, Sale of SOZO Device and Software Subscription Services.

News

Intraday Update

Markets

Movers

Trading Ideas

ABEV

ABIO

ABMD

ABVC

ACCYY

ACHV

ACIW

ACOR

ACRFF

ACRX

ACSAY

ACST

ADHC

ADMA

ADMP

AEGOF

AFLYY

AFRAF

AGCO

AGEEF

AHKSY

AHOTF

AIBGY

AIPUY

AKRX

ALDX

ALEAFIA HEALTH INC ORD by Aleafia Health Inc.

ALEAF

ALLY

ALMFF

ALOT

ALSN

ALTM

ALXN

AMADY

AMCX

AMKBF

AMKBY

AMNP

AMPH

AMRH

AMRQQ

AMTX

ANAT

ANCN

ANGO

ANIP

ANZLY

APEX

APHA

APLE

APTS

AQARF

ARCB

ARCH

ARGGY

ARGO

ARLP

ARNA

ARNGF

AROC

ARREF

ARTL

ASNA

ASTVF

ATRA

ATRI

ATROB

ATSG

ATUSF

AUTL

Stocks That Hit 52-Week Lows On Thursday

ALXEF

BRGGF

CCRGF

CDGXF

CEIX

CWBHF

DDMX

DRRSF

ECOR

ELGX

EMERALD HEALTH THERAPUTCS by Emerald Health Therapeutics Inc.

EMHTF

FEWP

FLWPF

FNGR

GAXY

GAYGF

GCAN

GFTX

GGBXF

GLBS

GNMK

GPOR

GSUM

HAPP

HESG

HRVOF

IDGBF

INDXF

INND

IPDQF

KAYS

KRKR

MFCSF

MJNE

MMNFF

MODERN CINEMA GROUP INC by Modern Cinema Group, Inc.

MOCI

MRAM

MTTWF

NAKD

NOSUF

OWPC

OWRDF

PACB

PDSB

PFGTF

PHIO

PROS

RDDTF

REPO

RNLSY

ROSE

RYDBF

RYPPF

SEEK

SEXHF

SINT

SNDL

SNNVF

SPRWF

SPSTF

STGPF

STWC

TGIFF

TNXP

TSRYY

TUWOY

VBIX

VLRX

XERS

YAYO

VRSRF

SPOI

AZIL

Stocks That Hit 52-Week Lows On Tuesday

Impedimed Ltd

Wilsons analyst Shane Storey maintained a Buy rating on Impedimed Limited (IPDQF – Research Report) on July 20 and set a price target of A$0.39. Th...

Wilsons Sticks to Its Buy Rating for Impedimed Limited (IPDQF)

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Telix Pharmaceuticals Ltd. (TLPPF – Research Report)...

Analysts Are Bullish on Top Healthcare Stocks: Telix Pharmaceuticals Ltd. (TLPPF), Impedimed Limited (IPDQF)

In a report released today, Scott Power from Morgans maintained a Buy rating on Impedimed Limited (IPDQF – Research Report), with a price target of...

Morgans Sticks to Their Buy Rating for Impedimed Limited (IPDQF)

Canaccord Genuity analyst Elyse Shapiro maintained a Buy rating on Impedimed Limited (IPDQF – Research Report) on September 28 and set a price targ...

Canaccord Genuity Reaffirms Their Buy Rating on Impedimed Limited (IPDQF)

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Impedimed Limited (IPDQF – Research Report) and Illu...

Analysts Offer Insights on Healthcare Companies: Impedimed Limited (OtherIPDQF) and Illumina (ILMN)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Impedimed Limited (IPDQF – Research Report), Qiagen (QGEN – Resea...

Analysts Offer Insights on Healthcare Companies: Impedimed Limited (OtherIPDQF), Qiagen (QGEN) and Axonics Modulation Technologies (AXNX)

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Eli Lilly & Co (LLY – Research Report), Exelixis (EX...

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Exelixis (EXEL) and Impedimed Limited (OtherIPDQF)

Impedimed Limited (AU:IPD) has released an update. Impedimed Limited has announced the cessation of over 10 million securities, including options a...

Impedimed Announces Over 10M Securities Cessation

In a report released today, Tom Godfrey from Ord Minnett maintained a Buy rating on Impedimed Limited (IPDQF – Research Report), with a price targe...

Impedimed Limited (IPDQF) Gets a Buy from Ord Minnett

Impedimed Limited (AU:IPD) has released an update. ImpediMed Limited is set to reduce its operating costs by 10-15% by the end of FY24 through orga...

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Latest News for Impedimed Stock (OTC:IPDQF)

Thursday, February 27, 2020

Tuesday, February 11, 2020